Delivery Order SPE2DB25D3404-SPE2DB26FULTJ
- Not listed
- The Defense Logistics Agency awarded a $1,185.93 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The order is scheduled for completion by September 18, 2025, and will be fulfilled from the contractor's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,428.90 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages on September 11, 2025, with completion scheduled for September 12, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside restrictions, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a $1,296 delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This is a firm fixed-price contract with an ultimate completion date of October 17, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitive award. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with a ceiling value of $1,976.82. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The work is scheduled for completion by August 22, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages, valued at $1,336.44 with firm fixed pricing. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025, and the product will be performed/delivered from the contractor's location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award issued as a child delivery order under a larger indefinite delivery...
- The Defense Logistics Agency awarded a $1,628.40 delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages on September 5, 2025, with completion scheduled for September 8, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside transaction for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,308.49 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This is a firm fixed price delivery order with no set-aside designation, competitively awarded on September 5, 2025, with an ultimate completion date of September 8, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office and primary operations. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose packets of 5 grams. The contract represents a firm fixed price delivery order with a ceiling value of $1,097.46 and an ultimate completion date of October 22, 2025. This award is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Testosterone 1% (50 mg/5g) in unit-dose 5-gram packets, with a contract ceiling value of $1,794.90. This is a firm fixed price delivery order with an ultimate completion date of September 24, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (25 mg/2.5 g) in 2.5 gram packages, with a contract value of $1,727.35. The award, issued on May 14, 2025, is a firm fixed price delivery order with an ultimate completion date of May 15, 2025. This is a non-set-aside competitive award, and the place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB26FULTJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with a contract value of $3,503.54 and completion deadline of October 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a small-value transaction typical of the Defense Logistics Agency's medical supply procurement operations supporting military healthcare requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor under this comprehensive global contract vehicle, AmerisourceBergen Drug Corp supplies a broad spectrum of medications and medical commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's federal contracting activity demonstrates significant capability in meeting competitive federal pharmaceutical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 10/21/25 |